Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness
MP Gulseth, AK Wittkowsky, J Fanikos… - … : The Journal of …, 2011 - Wiley Online Library
A number of novel anticoagulants are moving through various stages of drug development.
Recently, the United States Food and Drug Administration approved the oral direct thrombin …
Recently, the United States Food and Drug Administration approved the oral direct thrombin …
[引用][C] Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness: ANTICOAGULATION
MP GULSETH, AK WITTKOWSKY… - …, 2011 - pascal-francis.inist.fr
Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and
Effectiveness : ANTICOAGULATION CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Effectiveness : ANTICOAGULATION CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness
MP Gulseth, AK Wittkowsky, J Fanikos… - …, 2011 - pubmed.ncbi.nlm.nih.gov
A number of novel anticoagulants are moving through various stages of drug development.
Recently, the United States Food and Drug Administration approved the oral direct thrombin …
Recently, the United States Food and Drug Administration approved the oral direct thrombin …
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
MP Gulseth, AK Wittkowsky, J Fanikos… - …, 2011 - europepmc.org
A number of novel anticoagulants are moving through various stages of drug development.
Recently, the United States Food and Drug Administration approved the oral direct thrombin …
Recently, the United States Food and Drug Administration approved the oral direct thrombin …